MoonLake Immunotherapeutics MLTX Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's other noncash income (expense)?
- MoonLake Immunotherapeutics (MLTX) reported other noncash income (expense) of -$422K in Q1 2026.
- How has MoonLake Immunotherapeutics's other noncash income (expense) changed year-over-year?
- MoonLake Immunotherapeutics's other noncash income (expense) decreased by 240.3% year-over-year, from -$124K to -$422K.
- What is the long-term trend for MoonLake Immunotherapeutics's other noncash income (expense)?
- Over 2 years (2022 to 2024), MoonLake Immunotherapeutics's other noncash income (expense) has grown at a 90.0% compound annual growth rate (CAGR), from -$68.45K to $247K.
- What does other noncash income (expense) mean?
- This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.